|
| 肿瘤医院2004年放化疗止吐药应用分析 |
| Analysis of Application of Anti-vomiting Medicine for Actinotheraphy or Chemotherapy in our Institute in 2004 |
| 投稿时间：2005-06-28 修订日期：2005-10-28 |
| DOI： |
| 中文关键词: 止吐药 肿瘤医院 放疗 化疗 药物利用 |
| 英文关键词:Anti-vomiting medicine Actinotberaphy Chemotherapy Application analysis |
| 基金项目: |
| 王新华 陈东生 |
| 华中科技大学同济医学院附属协和肿瘤医院药械科,武汉430023 |
| 摘要点击次数: 1693 |
| 全文下载次数: 111 |
| 中文摘要: |
| 目的：调查肿瘤专科医院放、化疗患者止吐药的应用情况，做出客观评价。方法：对我院2004年住院患者使用止吐药的人数、性别、年龄、病种及用药频率、购药金额、每日费用等进行统计分析。结果：我院止吐药主要品种有8种，DDDS在前4位的药品高、中、低档均有；注射剂DDDS百分比和销售金额百分比分别为99．66％和99．67％；肺癌、鼻咽癌、非何杰金氏淋巴瘤患者人数居前3位。结论：放化疗患者止吐趋向于注射剂。我院止吐药的使用基本合理。 |
| 英文摘要: |
| Objective: To investigate the application of anti-vomiting medicine for the actinotheraphy or chemotherapy in our institute and provide an objective evaluation. Method: The users'figure, sex, age and cases and the use frequency, purchase sum and p. d. expenses of anti - vomiting medicine in our institute in 2004 were analyzed. Result: The four leading DDDs of the 8 kinds of anti-vomiting medicine used in our institute were advanced, medium and low. The frequency of DDDs injection was 99.66% and the selling sum was 99.67%. The three main users were the patients who suffered from lung cancer, carcinoma of nasopharynx or Non-Hodg Kin's Lymphoma. Conclusion: The injection has become the trend for actinotheraphy or chemotherapy with the anti-vomiting medicine. The three leading users are the patients whose age is between 31-61 and older. The usage of anti-vomiting medicine in our institute is reasonable on the whole. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
